Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06661473 · ClinicalTrials.gov registry record · NA
Interventional Study Exploring the Occurrence of Surgical Site Infections.
A NA study of Total Knee Arthroplasty and Total Hip Arthroplasty Revision, sponsored by Molnlycke Health Care AB.
- Active
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 8
- Study locations
NCT06661473: Active NA study of Total Knee Arthroplasty and Total Hip Arthroplasty Revision, sponsored by Molnlycke Health Care AB.
NCT06661473 is a NA study of Total Knee Arthroplasty and Total Hip Arthroplasty Revision that is active but no longer recruiting, run by Molnlycke Health Care AB. The registered enrollment target is 105 participants, below the 291-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (64% lower). The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06661473, a NA study of Total Knee Arthroplasty and Total Hip Arthroplasty Revision, is active but no longer recruiting, sponsored by Molnlycke Health Care AB.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 8
- Study locations
Study Summary
Interventional study exploring surgical site complication occurrences in high-risk revision patients undergoing TKA or THA using NPWT.
Conditions Studied
Interventions
- DEVICE Avance Solo Negative Pressure Wound Therapy
Study Locations (8)
District of Columbia
- MedStar Health - Washington D.C.
Indiana
- Ortho Indy - Indianapolis
Maryland
- Life Bridge Health- Sinai Hospital - Baltimore
Minnesota
- Twin Cities Orthopedics - Minneapolis
Missouri
- St. Louis University - St Louis
New York
- Northwell - Garden City
Ohio
- Bon Secours Mercy Health - Youngstown
Washington
- Spokane Joint Replacement Center - Spokane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2026-01 |
| Phase | NA |
What the registry record for NCT06661473 still lists
NCT06661473 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 291-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (64% lower).
The record links to 3 conditions, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which Avance Solo Negative Pressure Wound Therapy is the first listed.
NCT06661473 lists 8 locations in 8 states (District of Columbia, Indiana, Maryland).
Frequently Asked Questions
What is clinical trial NCT06661473 about?
NCT06661473 is a clinical study titled "Interventional Study Exploring the Occurrence of Surgical Site Infections.". Interventional study exploring surgical site complication occurrences in high-risk revision patients undergoing TKA or THA using NPWT.
What is the current status of trial NCT06661473?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 105 participants. The study started on 2024-10-03. Estimated completion is 2026-01.
What conditions does trial NCT06661473 study?
This clinical trial studies the following conditions: Total Knee Arthroplasty, Total Hip Arthroplasty Revision, Total Knee Arthroplasty Revision.
What interventions are being tested in trial NCT06661473?
The interventions under investigation include: Avance Solo Negative Pressure Wound Therapy (DEVICE).
Who is sponsoring clinical trial NCT06661473?
This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06661473 being conducted?
This trial has 8 study locations across District of Columbia, Indiana, Maryland, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Knee Arthroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06661473's enrollment target sits among peer trials
105 18th of 29 higher than 12 of 29 other Total Knee Arthroplasty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Total Knee Arthroplasty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intraoperative VR for Older Patients Undergoing TKA
RECRUITING · NA
-
Investigating Patient Satisfaction With Smart Knee Implants
RECRUITING · NA
-
Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty
RECRUITING · NA
-
Minimal Sedation During Knee Replacement Surgery
RECRUITING · NA
-
Effectiveness of Exparel Anesthetic Administered by the Surgeon During Knee Surgery
RECRUITING · NA
-
Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI